|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Linares MA, Zakaria A and Nizran P: Skin
cancer. Prim Care. 42:645–659. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Singh S, Zafar A, Khan S and Naseem I:
Towards therapeutic advances in melanoma management: An overview.
Life Sci. 174:50–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gray-Schopfer V, Wellbrock C and Marais R:
Melanoma biology and new targeted therapy. Nature. 445:851–857.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gros A, Parkhurst MR, Tran E, Pasetto A,
Robbins PF, Ilyas S, Prickett TD, Gartner JJ, Crystal JS, Roberts
IM, et al: Prospective identification of neoantigen-specific
lymphocytes in the peripheral blood of melanoma patients. Nat Med.
22:433–438. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Slominski AT and Carlson JA: Melanoma
resistance: A bright future for academicians and a challenge for
patient advocates. Mayo Clin Proc. 89:429–433. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shah DJ and Dronca RS: Latest advances in
chemotherapeutic, targeted, and immune approaches in the treatment
of metastatic melanoma. Mayo Clin Proc. 89:504–519. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smith MA and Mattick JS: Structural and
functional annotation of long noncoding RNAs. Methods Mol Biol.
1526:65–85. 2017. View Article : Google Scholar
|
|
9
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun M, Xia R, Jin F, Xu T, Liu Z, De W and
Liu X: Downregulated long noncoding RNA MEG3 is associated with
poor prognosis and promotes cell proliferation in gastric cancer.
Tumour Biol. 35:1065–1073. 2014. View Article : Google Scholar
|
|
12
|
Sun M, Jin FY, Xia R, Kong R, Li JH, Xu
TP, Liu YW, Zhang EB, Liu XH and De W: Decreased expression of long
noncoding RNA GAS5 indicates a poor prognosis and promotes cell
proliferation in gastric cancer. BMC Cancer. 14:3192014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cai X, Liu Y, Yang W, Xia Y, Yang C, Yang
S and Liu X: Long noncoding RNA MALAT1 as a potential therapeutic
target in osteosarcoma. J Orthop Res. 34:932–941. 2016. View Article : Google Scholar
|
|
14
|
Guo Q, Zhao Y, Chen J, Hu J, Wang S, Zhang
D and Sun Y: BRAF-activated long non-coding RNA contributes to
colorectal cancer migration by inducing epithelial-mesenchymal
transition. Oncol Lett. 8:869–875. 2014.PubMed/NCBI
|
|
15
|
Sun M, Liu XH, Wang KM, Nie FQ, Kong R,
Yang JS, Xia R, Xu TP, Jin FY, Liu ZJ, et al: Downregulation of
BRAF activated non-coding RNA is associated with poor prognosis for
non-small cell lung cancer and promotes metastasis by affecting
epithelial-mesenchymal transition. Mol Cancer. 13:682014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Guo Q, Zhao Y, Chen J, Wang S, Hu
J and Sun Y: BRAF-activated long non-coding RNA contributes to cell
proliferation and activates autophagy in papillary thyroid
carcinoma. Oncol Lett. 8:1947–1952. 2014.PubMed/NCBI
|
|
17
|
Li R, Zhang L, Jia L, Duan Y, Li Y, Bao L
and Sha N: Long non-coding RNA BANCR promotes proliferation in
malignant melanoma by regulating MAPK pathway activation. PLoS One.
9:e1008932014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Leucci E, Coe EA, Marine JC and Vance KW:
The emerging role of long non-coding RNAs in cutaneous melanoma.
Pigment Cell Melanoma Res. 29:619–626. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Philippidou D, Schmitt M, Moser D, Margue
C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I and Kreis
S: Signatures of microRNAs and selected microRNA target genes in
human melanoma. Cancer Res. 70:4163–4173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang D, Wang D, Wang N, Long Z and Ren X:
Long non-coding RNA BANCR promotes endometrial cancer cell
proliferation and Invasion by regulating MMP2 and MMP1 via ERK/MAPK
signaling pathway. Cell Physiol Biochem. 40:644–656. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lv L, Jia JQ and Chen J: LncRNA CCAT1
upregulates proliferation and invasion in melanoma cells via
suppressing miR-33a. Oncol Res. Apr 12–2017.Epub ahead of print.
View Article : Google Scholar : 2017.PubMed/NCBI
|
|
22
|
Sun Y, Cheng H, Wang G, Yu G, Zhang D,
Wang Y, Fan W and Yang W: Deregulation of miR-183 promotes melanoma
development via lncRNA MALAT1 regulation and ITGB1 signal
activation. Oncotarget. 8:3509–3518. 2017.
|
|
23
|
Massi D, Tarantini F, Franchi A,
Paglierani M, Di Serio C, Pellerito S, Leoncini G, Cirino G,
Geppetti P and Santucci M: Evidence for differential expression of
Notch receptors and their ligands in melanocytic nevi and cutaneous
malignant melanoma. Modern Pathol. 19:246–254. 2006. View Article : Google Scholar
|
|
24
|
Suliman MA, Zhang Z, Na H, Ribeiro AL,
Zhang Y, Niang B, Hamid AS, Zhang H, Xu L and Zuo Y: Niclosamide
inhibits colon cancer progression through downregulation of the
Notch pathway and upregulation of the tumor suppressor miR-200
family. Int J Mol Med. 38:776–784. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chegeni S, Khaki Z, Shirani D, Vajhi A,
Taheri M, Tamrchi Y and Rostami A: Investigation of MMP-2 and MMP-9
activities in canine sera with dilated cardiomyopathy. Iran J Vet
Res. 16:182–187. 2015.
|
|
26
|
Mikhaylova O, Stratton Y, Hall D, Kellner
E, Ehmer B, Drew AF, Gallo CA, Plas DR, Biesiada J, Meller J, et
al: VHL-regulated miR-204 suppresses tumor growth through
inhibition of LC3B-mediated autophagy in renal clear cell
carcinoma. Cancer Cell. 21:532–546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bao W, Wang HH, Tian FJ, He XY, Qiu MT,
Wang JY, Zhang HJ, Wang LH and Wan XP: A TrkB-STAT3-miR-204-5p
regulatory circuitry controls proliferation and invasion of
endometrial carcinoma cells. Mol Cancer. 12:1552013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yin Y, Zhang B, Wang W, Fei B, Quan C,
Zhang J, Song M, Bian Z, Wang Q, Ni S, et al: miR-204-5p inhibits
proliferation and invasion and enhances chemotherapeutic
sensitivity of colorectal cancer cells by downregulating RAB22A.
Clin Cancer Res. 20:6187–6199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar
|
|
30
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Berrondo C, Flax J, Kucherov V, Siebert A,
Osinski T, Rosenberg A, Fucile C, Richheimer S and Beckham CJ:
Expression of the long non-coding RNA HOTAIR correlates with
disease progression in bladder cancer and is contained in bladder
cancer patient urinary exosomes. PLoS One. 11:e01472362016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schmidt K, Joyce CE, Buquicchio F, Brown
A, Ritz J, Distel RJ, Yoon CH and Novina CD: The lncRNA SLNCR1
mediates melanoma invasion through a conserved SRA1-like region.
Cell Rep. 15:2025–2037. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Khaitan D, Dinger ME, Mazar J, Crawford J,
Smith MA, Mattick JS and Perera RJ: The melanoma-upregulated long
noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer
Res. 71:3852–3862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li T, Pan H and Li R: The dual regulatory
role of miR-204 in cancer. Tumour Biol. 37:11667–11677. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ding M, Lin B, Li T, Liu Y, Li Y, Zhou X,
Miao M, Gu J, Pan H, Yang F, et al: A dual yet opposite
growth-regulating function of miR-204 and its target XRN1 in
prostate adenocarcinoma cells and neuroendocrine-like prostate
cancer cells. Oncotarget. 6:7686–7700. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tan X, Huang Z and Li X: Long Non-coding
RNA MALAT1 interacts with miR-204 to modulate human hilar
cholangiocarcinoma proliferation, migration, and invasion by
targeting CXCR4. J Cell Biochem. 118:3643–3653. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Maillard I, Fang T and Pear WS: Regulation
of lymphoid development, differentiation, and function by the Notch
pathway. Annu Rev Immunol. 23:945–974. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schouwey K, Aydin IT, Radtke F and
Beermann F: RBP-Jκ-dependent Notch signaling enhances retinal
pigment epithelial cell proliferation in transgenic mice. Oncogene.
30:313–322. 2011. View Article : Google Scholar
|
|
40
|
Asnaghi L, Ebrahimi KB, Schreck KC, Bar
EE, Coonfield ML, Bell WR, Handa J, Merbs SL, Harbour JW and
Eberhart CG: Notch signaling promotes growth and invasion in uveal
melanoma. Clin Cancer Res. 18:654–665. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Forloni M, Dogra SK, Dong Y, Conte D Jr,
Ou J, Zhu LJ, Deng A, Mahalingam M, Green MR and Wajapeyee N:
miR-146a promotes the initiation and progression of melanoma by
activating Notch signaling. eLife. 3:e014602014. View Article : Google Scholar : PubMed/NCBI
|
